Cardiovalve
Or Yehuda · Founded 2017
About Cardiovalve
Cardiovalve is a medical device company developing a transfemoral mitral valve replacement system. The flagship Cardiovalve system is the first one designed to replace the mitral valve using a transfemoral system. It is designed from the bottom up for transfemoral/transseptal delivery with femoral venous access. Cardivalve approach offers significant benefits, including a short profile for minimal protrusion to the left ventricle, minimizing interference in the cardiac blood flow and increased safety. It is currently evaluating the safety and performance of its system in clinical studies and it will seek EU and US approval.
Company Facts
- Founded: 2017
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Series Unknown (Aug 2020)
- Website: cardiovalve.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/cardiovalve-8432975 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.